Certara is the leading drug development consultancy with solutions spanning the discovery, preclinical and clinical stages of drug development.
David Lowis described a case study where D360 was used to replace older technologies at a biotechnology company. He also showed D360’s new visualization tools and shares the future roadmap as D360 advances its support of biologics in addition to small molecules.
Read MorePRINCETON, NJ – Feb. 14, 2018 – Certara today announced the launch of version 10 of D360, its data informatics platform for discovery scientists. D360 is a self-service data access, integration and visualization solution used to query diverse cheminformatics and bioinformatics data sources to make informed go/no go research decisions.
Read MoreD360 Partner is an affordable add-on product for D360 for external partners that allows for seamless, secure sharing of data and analysis while advancing communication and collaboration.
Read MoreD360 Express is an out-of-the-box integrated solution specifically designed for discovery scientists at smaller pharmaceutical research organizations. It provides access, integration, analysis and visualization of scientific data from multiple data sources. D360 Express gets you up and running quickly and affordably.
Read MoreScientific Data Informatics Hub for Discovery Research Small molecule drug discovery research requires the ability to access and understand biological, chemical, logistical, and computational data from a wide variety of sources. A major challenge for scientists is the significant time and resources needed to find and access this data quickly and efficiently in order to make […]
Read MoreD360 removes the major roadblocks that preclinical scientists encounter when answering questions related to safety data by making the data easily available, in a format that is readily accessible and usable. As a result, answers are arrived at quickly and easily, and scientists are enabled to ask questions that were previously impossible to ask.
Read MoreD360 brings together data from different sources and provides integrated analysis and collaboration tools to support a wide variety of workflows across scientific disciplines.
Read MoreDiscovery drug research requires understanding complex biological, chemical, logistical and computational data from a wide variety of data sources. Certara’s D360 platform was specifically designed to meet the discovery researcher’s workflow needs.
Read MorePRINCETON, NJ – June 23, 2016 – The D360 packaged informatics solution reduces research cycle time, delivering faster insights for busy discovery scientists.
Read MoreProviding scientists with access to project data and tools to analyze and collaborate is vitally important to improving the effectiveness of rational, data-driven research. This capability must be provided without undue burden or cost on already stretched IT resources. D360™ is a scientific informatics tool that meets these criteria.
Read MoreCertara’s D360 enables scientists to focus on uncovering trends in their data, without the pain of figuring out how to access it. A global top 10 pharmaceutical company, devoted to discovering new medicines and new technologies for managing personal health, engaged in an initiative to better address cross-study analysis of pre-clinical safety data. Toxicologists, pathologists, […]
Read MoreD360 enables scientists to easily access, analyze, and visualize chemical and biological data, enhance scientific capabilities. A small biotechnology company dedicated to the research and development of small molecule therapeutics engaged in an initiative to better address access and analysis of chemical and biological data by its scientists. Scientists at this company use IDBS’ ActivityBase®, […]
Read MoreA top 40 pharmaceutical company enhanced data access and decision support for pre-clinical safety with Certara’s D360 data access and analysis application and a specialized CDISC SEND-based database. Pre-clinical scientists at a top 40 pharmaceutical company faced delays of a day or more for data collation and transformation with each incremental data update received from […]
Read MoreDiscovery team lowers IT costs and improves end-user functionality by standardizing on Certara’s D360 Drug Discovery Platform A multi-national pharmaceutical company had developed a custom informatics system, providing all scientists in its discovery organization with access to essential research data. While information access was well-served by the tool, over time, a long list of new […]
Read MoreMedivir sees a fast return on its investment — time savings and enhanced informativeness of data activities The discovery arm of Medivir®, a mid-size, Swedish pharmaceutical company, sought an updated informatics infrastructure to improve the efficiency and flexibility of its data analysis and reporting. The group’s existing in-house tools could only create reports in a […]
Read MoreData Informatics Platform for Discovery Scientists Small molecule drug discovery research requires understanding complex biological, logistical, and computational data from a wide variety of data sources. A key challenge for discovery scientists is the ability to efficiently access the most current and relevant data from internal and external data sources, ideally in a consolidated and cohesive […]
Read MoreCertara’s Informatics Platform Facilitates Scientific Data Access, Analysis and Collaboration within an Organization and Amongst Development Partners D360 Data Informatics Platform for Discovery Scientists D360™ is the industry-leading scientific data informatics hub used globally by over 5,000 discovery research scientists. It was designed to meet the discovery researcher’s workflow needs by providing a self-service data […]
Read MoreIn this paper, we explore the issues in the effective use of modern pharmaceutical data mining applications. We discuss the development and capabilities that were built into the Discovery 360° application to address these issues, as part of Wyeth Pharmaceuticals Next Generation IT project (NextGen). Wyeth found that simplifying data access and integration of data […]
Read More
As the end of the year draws near, I want to thank all of our customers for letting us be your biosimulation and model based drug development solution provider. We feel honored to be able to play a small, but crucial role in your success in bringing safe and effective drugs to patients. 2014 has […]
Read More